Gene-Tailored therapy shows promise for advanced lung cancer
Disease control
Completed
This study tested whether customizing chemotherapy based on specific gene mutations (EGFR and BRCA1) could improve outcomes for 153 patients with advanced lung adenocarcinoma. Participants received treatments matched to their tumor's genetic profile. The goal was to see if this p…
Phase: NA • Sponsor: Spanish Lung Cancer Group • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC